يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"Yuriy Vinnyk"', وقت الاستعلام: 0.61s تنقيح النتائج
  1. 1
    Phase III, Randomized, Double-Blind Study Comparing the Efficacy, Safety, and Immunogenicity of SB3 (Trastuzumab Biosimilar) and Reference Trastuzumab in Patients Treated With Neoadjuvant Therapy for Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer

    المؤلفون: Yuriy Vinnyk, Marek Z. Wojtukiewicz, Yaroslav Shparyk, Xavier Pivot, Jin-Hee Ahn, Maximino De Guzman Bello, Sujeong Song, Vladimir Semiglazov, Zbigniew Nowecki, Sanjoy Chatterjee, Igor Bondarenko, Vladimir Moiseyenko, Seock-Ah Im, Ekaterina Trishkina, Jaeyun Lim, Tomasz Sarosiek, Mikhail Dvorkin

    المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 36(10)

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Cancer Research, medicine.medical_specialty, Cyclophosphamide, Receptor, ErbB-2, medicine.medical_treatment, Breast Neoplasms, Docetaxel, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Double-Blind Method, Trastuzumab, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Biosimilar Pharmaceuticals, Neoadjuvant therapy, Aged, Epirubicin, Chemotherapy, business.industry, Middle Aged, Neoadjuvant Therapy, Clinical trial, 030104 developmental biology, Fluorouracil, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a617ccd5cfa3ffdde8e7de18d79122c9Test
    https://pubmed.ncbi.nlm.nih.gov/29373094Test


    أضف إلى المفضلة
  2. 2
    One-year safety, immunogenicity, and survival results from a phase III study comparing SB3 (a proposed trastuzumab biosimilar) and originator trastuzumab in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment

    المؤلفون: Vladimir Semiglazov, Maximino De Guzman Bello, Xavier Pivot, S-A. Im, Marek Z. Wojtukiewicz, Jae Yun Lim, Yaroslav Shparyk, L. Younju, Zbigniew Nowecki, Sanjoy Chatterjee, Tomasz Sarosiek, J-H. Ahn, I. Bondarenko, Yuriy Vinnyk, Ekaterina Trishkina, Vladimir Moiseyenko, M. Dvorkin

    المصدر: ResearcherID

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, 030219 obstetrics & reproductive medicine, business.industry, medicine.medical_treatment, Immunogenicity, Biosimilar, Hematology, 03 medical and health sciences, 0302 clinical medicine, Trastuzumab, 030220 oncology & carcinogenesis, Internal medicine, medicine, business, Adjuvant, Early breast cancer, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32710c319c83b36d3955dc96f3e0c284Test
    http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000411324000081&KeyUID=WOS:000411324000081Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث